157 related articles for article (PubMed ID: 9835504)
1. Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats.
Kojima S; Nadai M; Kitaichi K; Wang L; Nabeshima T; Hasegawa T
Antimicrob Agents Chemother; 1998 Dec; 42(12):3136-40. PubMed ID: 9835504
[TBL] [Abstract][Full Text] [Related]
2. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.
Yamamura N; Imura K; Naganuma H; Nishimura K
Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803
[TBL] [Abstract][Full Text] [Related]
3. Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human.
Omoda K; Murakami T; Yumoto R; Nagai J; Maeda Y; Kiribayashi Y; Takano M
J Pharm Sci; 2005 Aug; 94(8):1685-93. PubMed ID: 15986463
[TBL] [Abstract][Full Text] [Related]
4. Interaction between valproic acid and carbapenem antibiotics.
Mori H; Takahashi K; Mizutani T
Drug Metab Rev; 2007; 39(4):647-57. PubMed ID: 18058328
[TBL] [Abstract][Full Text] [Related]
5. Panipenem-betamipron and decreases in serum valproic acid concentration.
Yamagata T; Momoi MY; Murai K; Ikematsu K; Suwa K; Sakamoto K; Fujimura A
Ther Drug Monit; 1998 Aug; 20(4):396-400. PubMed ID: 9712464
[TBL] [Abstract][Full Text] [Related]
6. [Seven cases of decreased serum valproic acid concentration during concomitant use of carbapenem antibiotics].
Lee SG; Kim JH; Joo JY; Kwon OH
Korean J Lab Med; 2007 Oct; 27(5):338-43. PubMed ID: 18094598
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats.
Nakajima Y; Mizobuchi M; Nakamura M; Takagi H; Inagaki H; Kominami G; Koike M; Yamaguchi T
Drug Metab Dispos; 2004 Dec; 32(12):1383-91. PubMed ID: 15345660
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats.
Torii M; Takiguchi Y; Saito F; Izumi M; Yokota M
J Pharm Pharmacol; 2001 Jun; 53(6):823-9. PubMed ID: 11428658
[TBL] [Abstract][Full Text] [Related]
9. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits.
Yokogawa K; Iwashita S; Kubota A; Sasaki Y; Ishizaki J; Kawahara M; Matsushita R; Kimura K; Ichimura F; Miyamoto K
Pharm Res; 2001 Sep; 18(9):1320-6. PubMed ID: 11683247
[TBL] [Abstract][Full Text] [Related]
10. The effect of carbapenem antibiotics on plasma concentrations of valproic acid.
Mancl EE; Gidal BE
Ann Pharmacother; 2009 Dec; 43(12):2082-7. PubMed ID: 19934386
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study.
Haroutiunian S; Ratz Y; Rabinovich B; Adam M; Hoffman A
J Clin Pharmacol; 2009 Nov; 49(11):1363-9. PubMed ID: 19773524
[TBL] [Abstract][Full Text] [Related]
12. Drug-drug interaction between valproic acid and meropenem: a retrospective analysis of electronic medical records from neurosurgery inpatients.
Wen ZP; Fan SS; Du C; Yin T; Zhou BT; Peng ZF; Xie YY; Zhang W; Chen Y; Xiao J; Chen XP
J Clin Pharm Ther; 2017 Apr; 42(2):221-227. PubMed ID: 28145574
[TBL] [Abstract][Full Text] [Related]
13. Panipenem does not alter the pharmacokinetics of the active metabolite of irinotecan SN-38 and inactive metabolite SN-38 glucuronide (SN-38G) in rats.
Kato A; Ueyama J; Abe F; Hotta K; Tsukiyama I; Oshima T; Kondo F; Saito H; Hasegawa T
Anticancer Res; 2011 Sep; 31(9):2915-22. PubMed ID: 21868538
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations.
Wu CC; Pai TY; Hsiao FY; Shen LJ; Wu FL
Ther Drug Monit; 2016 Oct; 38(5):587-92. PubMed ID: 27322166
[TBL] [Abstract][Full Text] [Related]
15. Concentration-dependent disposition of glucuronide metabolite of valproate.
Yu HY; Shen YZ
J Pharm Pharmacol; 2002 May; 54(5):633-9. PubMed ID: 12005358
[TBL] [Abstract][Full Text] [Related]
16. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid.
Lee SY; Huh W; Jung JA; Yoo HM; Ko JW; Kim JR
Drug Des Devel Ther; 2015; 9():4559-63. PubMed ID: 26309401
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic interaction between valproic acid and meropenem].
Sala Piñol F; Padullés Zamora N; Hidalgo Albert E; Clemente Bautista S; Cabañas Poy MJ; Oliveras Arenas M; Balcells Ramírez J
An Pediatr (Barc); 2006 Jan; 64(1):93-5. PubMed ID: 16539924
[TBL] [Abstract][Full Text] [Related]
18. Effects of Carnitine on Valproic Acid Pharmacokinetics in Rats.
Katayama H; Mizukami K; Yasuda M; Hatae T
J Pharm Sci; 2016 Oct; 105(10):3199-3204. PubMed ID: 27499337
[TBL] [Abstract][Full Text] [Related]
19. Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron.
Nagai K; Shimizu T; Togo A; Takeya M; Yokomizo Y; Sakata Y; Matsuishi T; Kato H
J Antimicrob Chemother; 1997 Feb; 39(2):295-6. PubMed ID: 9069562
[No Abstract] [Full Text] [Related]
20. Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride.
Khemawoot P; Maruyama C; Tsukada H; Noda H; Ishizaki J; Yokogawa K; Miyamoto K
Biopharm Drug Dispos; 2007 Sep; 28(6):331-8. PubMed ID: 17617793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
